Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

G. Facchini, S. Rossetti, M. Berretta, C. Cavaliere, S. Scagliarini, M.G. Vitale, C. Ciccarese, G. Di Lorenzo, E. Palesandro, V. Conteduca, U. Basso, E. Naglieri, A. Farnesi, M. Aieta, N. Borsellino, L. La Torre, G. Iovane, L. Bonomi, D. Gasparro, E. RicevutoM. De Tursi, R. De Vivo, G. Lo Re, F. Grillone, P. Marchetti, F. De Vita, C. Scavelli, C. Sini, S. Pisconti, A. Crispo, V. Gebbia, A. Maestri, L. Galli, U. De Giorgi, R. Iacovelli, C. Buonerba, G. Cartenì, C. D'Aniello

Research output: Contribution to journalArticle

Original languageEnglish
JournalJournal of Translational Medicine
Volume17
Issue number1
DOIs
Publication statusPublished - 2019

Cite this